Wingate Wealth Advisors Inc. Takes $82,000 Position in DaVita Inc. (NYSE:DVA)

Wingate Wealth Advisors Inc. purchased a new stake in DaVita Inc. (NYSE:DVA) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 545 shares of the company’s stock, valued at approximately $82,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. MML Investors Services LLC grew its stake in shares of DaVita by 1.3% in the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after acquiring an additional 68 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after buying an additional 68 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in DaVita by 1.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock worth $776,000 after buying an additional 70 shares in the last quarter. Impact Partnership Wealth LLC grew its stake in DaVita by 3.7% during the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after buying an additional 70 shares in the last quarter. Finally, Contravisory Investment Management Inc. grew its stake in DaVita by 1.2% during the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after buying an additional 73 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Barclays increased their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Stock Up 0.0 %

Shares of NYSE DVA opened at $173.63 on Tuesday. The company has a 50 day simple moving average of $160.79 and a 200 day simple moving average of $156.75. The firm has a market cap of $14.24 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 0.84 and a beta of 0.94. DaVita Inc. has a 1 year low of $108.76 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.